<DOC>
	<DOCNO>NCT00009854</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase I/II trial study effectiveness carmustine follow surgery treating patient recurrent supratentorial malignant glioma metastatic brain neoplasm .</brief_summary>
	<brief_title>Carmustine Followed By Surgery Treating Patients With Recurrent Supratentorial Malignant Glioma Metastatic Brain Neoplasm</brief_title>
	<detailed_description>OBJECTIVES : - Determine extent pattern distribution DNA adduct patient recurrent supratentorial malignant glioma metastatic neoplasm brain treat neoadjuvant intratumoral carmustine ethanol ( DTI-015 ) follow tumor resection . - Determine qualitative quantitative toxicity treatment regimen patient . OUTLINE : This dose escalation study . Patients receive neoadjuvant carmustine ethanol ( DTI-015 ) intratumorally stereotactic guidance 45-90 minute prior craniotomy tumor resection . Cohorts 3-6 patient receive escalate dos DTI-015 maximum tolerate dose ( MTD ) determine . The MTD define dose precede 3 3 3 6 patient experience dose-limiting toxicity . Patients follow 4 , 8 , 12 week , every 3 month thereafter . PROJECTED ACCRUAL : A total 15 patient accrue study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm recurrent supratentorial malignant glioma clear evidence progression MRI Glioblastoma multiforme Anaplastic ependymoma Anaplastic astrocytoma Anaplastic oligodendroglioma OR Metastatic tumor brain melanoma Planned resection tumor ( must first surgery recurrent disease ) Tumor volume tumor component residual tumor must least 4 cm3 great 33.4 cm3 Tumor shape surround structure ( ) unlikely cause irregular distribution inject study drug Tumor spherical , spheroid , ovoid No tumor shape 3 component ( e.g. , multicentric multilobulated ) No tumor extend ventricular system Tumor intact stroma ( i.e. , tumor mass partially incise puncture ) Central necrosis and/or central cystic area allow enhance rim thickness 5 mm present No tumor follow location brain : Brainstem ( pons medulla ) Midbrain ( mesencephalon ) Primary sensorimotor cortex dominant hemisphere Within 1.5 cm optic chiasm , either optic nerve , cranial nerve PATIENT CHARACTERISTICS : Age : 18 75 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 No evidence bleed diathesis Hepatic : Bilirubin great 2.0 mg/dL SGOT SGPT great 2.5 time normal Renal : Creatinine great 2.0 mg/dL OR Creatinine clearance least 40 mL/min OR BUN great 30 mg/dL Other : No active uncontrolled infection Afebrile ( 37.5 degree C ) unless fever due tumor No unstable severe medical condition No complicate medical psychiatric problem would preclude study Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since prior systemic chemotherapy ( 6 week nitrosoureas , mitomycin , Gliadel wafer ) recover No antitumor chemotherapy within 12 week study drug unless tumor volume increase 25 % MRI Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy recover No prior intracranial brachytherapy No antitumor radiotherapy within 12 week study drug unless tumor volume increase 25 % MRI Surgery : See Disease Characteristics Prior surgery allow No antitumor surgery within 12 week study drug Other : No concurrent anticoagulants No concurrent investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2003</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>tumor metastatic brain</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>